The murine olfactory system consists of main and accessory systems that perform distinct and overlapping functions. The main olfactory epithelium (MOE) is primarily involved in the detection of volatile odorants, while neurons in the vomeronasal organ (VNO), part of the accessory olfactory system, are important for pheromone detection. During development, the MOE and VNO both originate from the olfactory pit; however, the mechanisms regulating development of these anatomically distinct organs from a common olfactory primordium are unknown. Here we report that two closely related zincfinger transcription factors, FEZF1 and FEZF2, regulate the identity of MOE sensory neurons and are essential for the survival of VNO neurons respectively. Fezf1 is predominantly expressed in the MOE while Fezf2 expression is restricted to the VNO. In Fezf1-deficient mice, olfactory neurons fail to mature and also express markers of functional VNO neurons. In Fezf2-deficient mice, VNO neurons degenerate prior to birth. These results identify Fezf1 and Fezf2 as important regulators of olfactory system development and sensory neuron identity.
INDEXING TERMS: main olfactory epithelium; vomeronasal organ; olfactory receptor; vomeronasal receptor; cell fate To perceive their chemical environment, mice coordinate the functions of the main and accessory olfactory systems. The main olfactory system is composed of the main olfactory epithelium (MOE) and the main olfactory bulb, which are involved in odorant detection. Alternatively, the accessory olfactory system consists of the vomeronasal organ (VNO), the Grüneberg ganglion, the septal organ of Masera, and the accessory olfactory bulb (Munger et al., 2009) . The best-studied of these accessory sense organs, the VNO, is primarily involved in pheromone detection (Dulac and Torello, 2003) . Thus, the MOE and VNO are considered functionally and anatomically distinct organs.
During midgestation the MOE and VNO both originate from the bilaterally symmetrical olfactory pits, which are invaginations of epithelial and underlying mesenchymal cells (Fig. 1A ) (Balmer and LaMantia, 2005) . At embryonic day (E)9.5 the olfactory pits first develop as a thickening of the frontal epithelial cell layer of the developing embryo known as the olfactory placode. The olfactory placode begins to show signs of neural differentiation such as btubulin and neural cell adhesion molecule (NCAM) expression, and by E10.5 has undergone an initial invagination to produce the two olfactory pits (LaMantia et al., 2000) (Fig.  1A) . By E12.5 the olfactory pits undergo a second invagination in the ventromedial wall that produces the VNO (Fig.  1B) . The developing VNO separates from the olfactory pit and becomes a spatially distinct organ from the MOE by E14.5 (Fig. 1C,D) (Balmer and LaMantia, 2005) .
The mature MOE and VNO consist of a sensory neuron layer and an apical layer of supporting cells (Kawauchi et al., 2004) . The MOE also contains a basal layer of progenitor cells (Beites et al., 2005) . Tremendous progress has been made toward determining the signaling events in sensory neurons of the MOE and VNO (Mombaerts, 2004) . The mouse genome encodes about 1,000 G-protein-coupled olfactory receptor genes (ORs) and each sensory neuron of the MOE (OSN) expresses only one of these ORs. Binding of odorant molecules to an OR activates the OSN-specific G protein Ga olf , which then activates adenylate cyclase III (Jones and Reed, 1989) . The resulting increase in cAMP levels leads to the opening of olfactory cyclic nucleotide-gated channels and the propagation of an action potential (Liman and Buck, 1994) . In addition to the ORs, the mouse genome encodes two classes of G-protein-coupled pheromone receptors: V1Rs and V2Rs. Sensory neurons in the apical zone of the VNO (VSNs) express V1Rs and the G-protein subunit Gai2, while VSNs in the basal zone express V2Rs and Gao. Binding of pheromone molecules to V1Rs or V2Rs likely leads to the activation of the VNO-specific cation channel Trpc2. Axons from OSNs innervate the main olfactory bulb (MOB) while axons from the VSNs project to the accessory olfactory bulb (AOB) (Mombaerts, 2004) .
Significant advances have been achieved in understanding transcriptional control of OSN development. Mash1 is an important proneural gene in olfactory neurogenesis. It is expressed in the progenitor cells of MOE but not in differentiated OSNs (Gordon et al., 1995; Cau et al., 1997) . In Mash1 À/À mice, the number of mitotic progenitors and neurons are reduced in the MOE, and expression of the sustentacular cell marker Kitl is dramatically increased (Guillemot et al., 1993; Cau et al., 1997 Cau et al., , 2002 Murray et al., 2003) , indicating that Mash1 is critical for neuronal determination in the MOE. Two transcription factors, Hes1 and Wt1 (þKTS), have been shown to affect the expression of Mash1 (Cau et al., 2000 (Cau et al., , 2002 Wagner et al., 2005) , and mice carrying mutations in these genes show abnormal MOE neurogenesis (Cau et al., 2000 (Cau et al., , 2002 Wagner et al., 2005) . Many transcription factors, including Ngn1 (Cau et al., 1997 (Cau et al., , 2002 and Lhx2 (Cau et al., 2002; Hirota and Mombaerts, 2004; Kolterud et al., 2004) act downstream of Mash1 and are important for OSN differentiation. Additional transcription factors, such as members of O/E family (Wang et al., 1997 (Wang et al., , 2002 (Wang et al., , 2004 , Mecp2 (Ronnett et al., 2003; Matarazzo et al., 2004) , Dlx5 (Levi et al., 2003; Long et al., 2003) , and KLF7 (Luo et al., 1995; Laub et al., 2001; Tanaka et al., 2002) , function further downstream in OE development and regulate OSN maturation and axonal projections to the olfactory bulb (OB). Although these studies have focused on MOE and OSN development, many of these transcription factors are also expressed in the VNO, suggesting that similar mechanisms may regulate VSN development. Despite this progress, the mechanisms regulating the early cell fate decisions that generate the MOE and VNO, two distinct organs that develop from a common primordium, are not well understood. Fez family zinc-finger proteins 1 and 2 (FEZF1 and FEZF2) are two closely related transcription factors expressed early during mouse development that are important for brain development and cell identity. Fezf2 is required for proper fate specification of layer 5 subcortical projection neurons in the cerebral cortex (Chen et al., 2005a (Chen et al., ,b, 2008 Molyneaux et al., 2005) , while Fezf1 is essential for proper development of the OB and MOE (Hirata et al., 2006b; Watanabe et al., 2009 ). Furthermore, both Fezf1 and Fezf2 are required for regulation of forebrain size and patterning during early development (Hirata et al., 2006a; Shimizu et al., 2010) . Here we report the functions of Fezf1 and Fezf2 in establishing MOE neuronal identity and VNO development, respectively. We found that Fezf1 and Fezf2 show distinct expression patterns in the developing olfactory system. Fezf1 is expressed strongly in the MOE and weakly in the VNO, while Fezf2 is specifically and highly expressed in the VNO. Analysis of Fezf1 À/À and Fezf2 À/À mice indicates these genes are necessary for proper cell identity of olfactory sensory neurons (OSNs) and maintenance of the VNO, respectively. In Fezf1-deficient mice, OSNs fail to mature and express VNO-enriched neuronal markers. In contrast, Fezf2 mutant animals lack a VNO at birth. These results identify Fezf1 and Fezf2 as important regulators of olfactory system development and sensory neuron identity.
MATERIALS AND METHODS Generation of Fezf1
2/2 and Fezf1 2/2 ; Fezf2 2/2 mice A targeting vector was designed to replace the Fezf1 coding region with a cassette containing enhanced green fluorescent protein (EGFP) followed by an internal ribosome entry site (IRES)-human placental alkaline phosphatase Figure 1 . A diagram depicting the developmental origins of the MOE and VNO from the olfactory pit. All schematics shown depict a coronal orientation. A: At E10.5 the olfactory pit (shown in yellow) is morphologically discernible but does not show any distinction between the regions that will give rise to the MOE and VNO. B: By E12.5 the pit has undergone an initial invagination, distinguishing the dorsal region that will give rise to the MOE (purple) from the ventromedial region that will become the VNO (green). C: By E14.5 the VNO has separated from the pit and becomes anatomically distinct. D: This spatial and molecular distinction is clear at birth (P0), with both the MOE and VNO projecting axons to innervate the OB (gray). Diagrams are not drawn to scale.
(hPLAP) and PGK-neo ( Fig. 2A ). It contains a 3 kb homologous sequence upstream of and including the sequence encoding the first 10 amino acids of FEZF1, a 5.2 kb EGFP-IRES-hPLAP cassette, a 2 kb PGK-neo cassette, a 4.3 kb homologous sequence downstream of the Fezf1 gene, and the RSV-TK negative selection cassette. The junction of Fezf1 and EGFP was sequenced to ensure that no mutations were generated during cloning and that the EGFP ORF was in frame. The linearized knockout construct was electroporated into E14a ES cells, which were subjected to both positive and negative selections. Correctly targeted ES clones were identified by Southern hybridization. Two clones were used to generate chimeric mice by blastocyst injection. After germline transmission of the mutant allele, heterozygous Fezf1 þ/À mice were mated to b-actin-cre CD1 mice to excise the floxed pgkneo selection cassette. Fezf1 þ/À mice were then mated to generate Fezf1 À/À mice. Proper expression of the targeted allele was confirmed by in situ hybridization to detect hPLAP mRNA (Fig. 2C,D) . Generation of Fezf2 þ/À mice has been described previously (Chen et al., 2005a) . Fezf1 þ/À mice were bred with
each other generated animals carrying various combinations of Fezf1 and Fezf2 mutant alleles. Genotyping of Fezf1 alleles was accomplished by polymerase chain reaction (PCR) using two sets of primers. The wildtype allele was genotyped using p1 (ATGGACAG TAGCTGCCTCAACGCGACC) and p2 (ATGTTCACGCTCG CAGCCGGGTGGCAC), with an expected PCR product of 589 bp ( Fig. 2A,B) . The mutant Fezf1 allele was genotyped using p3 (GGGGAAGCTCTCTCACCAATG) and p4 (GGGGA AGCTCTCTCACCAATG), yielding the expected product of 460 bp ( Fig. 2A,B) . The PCR conditions were 94 C for 2 minutes, followed by 35 cycles of 94 C for 30 seconds, 64 C for 1 minute, and 72 C for 1 minute. Genotyping of Fezf2 alleles was reported previously (Chen et al., 2005a) .
The day of vaginal plug detection was designated as embryonic day 0.5 (E0.5). The day of birth was designated as postnatal day 0 (P0). Experiments were carried out in accordance with protocols approved by the IACUC at the University of California, Santa Cruz and were performed in accordance with institutional and federal guidelines. . Fezf1 knockout strategy. The endogenous Fezf1 locus was replaced with a cassette containing EGFP-IRES-hPLAP (A) and transmission of the targeted allele was confirmed by PCR using primers P1 and P2 (for wildtype allele), P3 and P4 (for mutant allele) (B). Appropriate expression of the targeted Fezf1 allele was confirmed by radioactive in situ hybridization to detect
but not in wildtype mice (C). Scale bar ¼ 100 lm in D.
Fezf1 and Fezf2 and olfactory development Figure 10 , 50 lm floating sections were processed for immunohistochemistry. Primary antibodies used are described in Table 1 . Primary antibodies were detected using AlexaFluor-conjugated secondary antibodies (Invitrogen, La Jolla, CA; 1:1,000). Nuclei in Figure 2 were visualized using SYTOX orange (Invitrogen, 1:100,000). Immunohistochemistry was performed as follows. Tissue sections were washed three times for 5 minutes each in phosphate-buffered saline (PBS, pH 7.4) and placed into blocking solution (10% horse serum, 0.3% Triton X-100 in PBS) for 1 hour at room temperature. Primary antibodies were added at the appropriate dilutions (Table 1) and incubated overnight at 4 C. The following day sections were washed three times in PBS and incubated with the secondary antibodies for 2 hours at room temperature. Sections were then washed three times in PBS and coverslipped with Fluoromount-G (Southern Biotech, Birmingham, AL).
Antibody characterization
The antibodies used in this study are listed in Table 1 . Characterization and controls for each primary antibody used are described below. The anti-cleaved caspase-3 antibody detects the large fragment (17/19 kDa) of caspase-3 resulting from cleavage adjacent to D175 in western blot analysis of extracts from HeLa, NIH/3T3, and C6 cells. It does not recognize full-length caspase-3 or other cleaved caspases (manufacturer's technical information). Immunostaining using this antibody detects apoptotic cells both in culture and in tissue sections. The specificity of the staining was confirmed by the use of blocking peptide in both western analysis and in immunohistochemistry. Antibody preincubated with control peptide stained cells in mouse embryonic tissue or human tonsil tissue sections, but antibody preincubated with cleaved caspase-3 (Asp175) blocking peptide (Cell Signaling, Beverly, MA; #1050) completely failed to stain mouse or human tissue sections. In addition, western blot analysis of cell extracts from Jukrat cells treated with 0.25 mg/mL cytochrome C (to induce apoptosis) using cleaved caspases-3 antibody showed specific bands at 17 and 19 kDa. Western blot analysis of the same cell extract using cleaved caspase-3 antibody preincubated with the blocking peptide (1/100) prevented the antibody from recognizing the 17/19 kDa bands (manufacturer's technical information).
The anti-GFP antibody labels neurons only in mice carrying an EGFP targeted allele or transgene and not in wildtype animals. This staining pattern recapitulates the intrinsic fluorescence of the EGFP (Eckler and Chen, unpubl. obs.) .
The anti-Ga s/olf antibody was developed against a rat C-terminal peptide (aa 377-394) (Daniel Crews, Santa Cruz Biotech, Santa Cruz, CA, pers. commun.). Western blotting of T98G or HeLa whole cell lysates recognizes 3 bands (52 kDa, 45 kDa, 39 kDa) corresponding to the long and short forms of Ga s and Ga olf (manufacturer's technical information). In our study, this antibody labeled the cilia of olfactory neurons, where olfactory receptors bind to odorant molecules and initiate cell signaling events. This staining pattern is consistent with the mRNA expression pattern of Ga s/olf , which was detected in the olfactory neurons of the MOE by in situ hybridization The anti-L1 rat monoclonal antibody was generated by immunizing rats with a glycoprotein fraction from P8-P9 mouse cerebellum. The antibody reacts with both mouse and rat tissues in immunohistochemistry. In western blot analysis, it recognizes the 220-240 kDa mouse L1 protein (manufacturer's technical information). The specificity of this antibody has been confirmed using L1 knockout mice. In lysates from mutant mice, western blot analysis showed a complete absence of the normal L1 protein. In wildtype mice, L1 staining was detected in the ventrallateral columns of spinal cord at E11.5 and in the dorsal root ganglion axons. In the L1 mutant mice, L1 staining was not detected (Cohen et al., 1998) . In the olfactory system and in mouse brains, this antibody labeled the cell body and projections of neurons.
Specificity of the anti-NCAM antibody has been demonstrated by the use of NCAM knockout animals. In NCAM À/À mice no staining was observed with this antibody (Schellinck et al., 2004) . We observed similar staining patterns to those previously described (Inaki et al., 2002; Taniguchi et al., 2003; Schellinck et al., 2004) , with strong labeling of neuronal cell bodies and projections. The anti-OMP antibody strongly labels mature sensory neurons throughout the olfactory system (Marcucci et al., 2009; Watanabe et al., 2009 ). This antibody recognizes a single band of 19 kD by western blot using mouse brain extract (Baker et al., 1989) . In tissue sections we observed strong labeling of cell bodies and axons of both OSNs and VSNs. This labeling pattern is consistent with the mRNA expression pattern of OMP detected by in situ hybridization (Eckler and Chen, unpubl. result) .
The anti-phosphorylated histone H3 (ser10) antibody detects endogenous levels of histone H3 only when phosphorylated at serine 10. This antibody does not crossreact with other phosphorylated histones or acetylated histone H3. The specificity of this antibody was confirmed using several assays. Western blot analysis of whole cell lysates from NIH/3T3 cells treated with serum plus calyculin A to induce histone H3 phosphorylation recognized a 16.5 kD band, which was not observed in untreated samples. Flow cytometric analysis of pacilitaxel-treated THP1 cells using this antibody versus propidium iodide showed that the cells stained by this antibody contained higher DNA content, corresponding to cells that passed S phase of the cell cycle. Costaining cultured NIH/3T3 cells with the anti-phosphorylated histone H3 antibody and with a tubulin antibody (to label microtubule cytoskeleton and mitotic spindles) showed that only dividing cells were stained by the anti-phosphorylated histone H3 antibody, and that nonmitotic cells were unstained. Immunohistochemical analysis of paraffin-embedded human carcinoma tissues using this anti-phosphorylated histone H3 antibody showed specific staining, but the staining was abolished when the tissue was treated with phosphatase, or when the antibody was preincubated with phospho-histone H3 (ser10) blocking peptide (#1000, Cell Signaling) (manufacturer's technical information). In our hands, this antibody strongly labeled cells in the ventricular and subventricular zone in developing mouse brains that were undergoing mitosis (Betancourt and Chen, unpubl. obs.).
PLAP staining
PLAP activity was detected with AP staining buffer (0.1 mg/mL 5-bromo-4-chloro-3-indolyl phosphate, 1 mg/mL nitroblue tetrazolium in 100 mM Tris-HCl pH 9.5, 100 mM NaCl) as previously described (Chen et al., 2008) .
In situ hybridization
In situ hybridization using 35 S-labeled probes was performed as previously described (Chen et al., 2005a) . Fresh-frozen olfactory tissue was fixed in 4% paraformaldehyde for 20 minutes at room temperature and then dehydrated with ethanol. Slides were treated with proteinase K for 30 minutes at room temperature, acetylated for 10 minutes, and then washed with 2Â SSC.
35
S-labeled cRNA probes were hybridized to sections overnight at 65 C. The following day slides were washed with SSC and subjected to RNase A digestion for 30 minutes at 37 C. Slides were then dehydrated and dipped in Kodak NTB2 emulsion 1:1 with distilled water. Kodak D19 and Rapid Fix solutions were used to develop the slides and cresyl violet was used as a counter stain.
Nonradioactive in situ hybridization was performed essentially as described (Schaeren-Wiemers and GerfinMoser, 1993) . Briefly, digoxigenin-labeled cRNA probes were synthesized for the genes of interest. Probes were hybridized to sections of fresh-frozen olfactory tissue overnight and visualized by the addition of NBT/BCIP substrate at room temperature.
Probes used in this study are described in Table 2 . In addition to their primary targets, the following probes likely crossreact with additional mRNAs based on their high degree of homology. The OR mix probe is 94% homologous to nucleotides 214-895 of Olfr1198 (NM_207567.1). The Taar mix probe is 98% homologous to nucleotides 3-863 of Taar8b (NM_001010837), 99% homologous to nucleotides 42-902 of Taar8c (NM_001010840), and 81% homologous to nucleotides 30-860 of Taar6 (NM_001010828.1). The V1R mix probe is 88% homologous to nucleotides 132-858 of V1rb1 
Microscopy
Confocal images were captured on a Leica TCS SP5 confocal microscope. Bright-and darkfield images were captured on an Olympus BX51 microscope using a Q Imaging Retiga EXj camera. Images were processed using Adobe Photoshop CS4 to adjust brightness and contrast.
Cell death and proliferation analysis E12.5 tissue sections were processed for immunohistochemistry with mouse anti-phosphorylated histone H3 and rabbit anti-cleaved caspase-3 antibodies. Total numbers of immunoreactive cells were counted on alternating 20-lm tissue sections for Fezf2 þ/À and Fezf2 À/À VNOs.
Total phosphorylated histone H3 þ and cleaved caspase-3 þ cells were averaged for each genotype and the standard error of mean (SEM) calculated. P-values were generated using a Student's t-test and statistical significance was assigned to P 0.05.
Isolation of Fezf1-EGFP 1 cells by FACS
The main olfactory epithelium from E18.5 Fezf1 þ/À or Fezf1 À/À animals was dissected in cold Neurobasal (NB) solution (Invitrogen) which had been equilibrated overnight were combined into a single expression score and converted to log 2 scale. Pairwise analysis was performed and transcript level changes with a fold enrichment of 1.75 or greater and an analysis of variance (ANOVA)-generated P-value of 0.05 or less were considered significant. All microarray data have been deposited in the Gene Expression Omnibus database at NCBI (Accession GSE26064).
In utero electroporation
EGFP or Fezf1 cDNA was cloned into the pCMV expression vector. EGFP or EGFP plus Fezf1 plasmids were electroporated into the cerebral cortex of E15.5 CD-1 embryos as described (Chen et al., 2008) . Animals were allowed to develop until P5 and axons were visualized by staining with EGFP antibodies.
RESULTS

Fezf1 and Fezf2 show distinct expression patterns during olfactory development
To investigate the expression patterns of Fezf1 and Fezf2 in the olfactory system we performed in situ hybridization using cRNA probes. Fezf1 expression was first detected in the olfactory placode at E9.5 (Fig. 3A) . At E10.5, Fezf1 mRNA was detected in the invaginating olfactory pit and expression continued postnatally in the olfactory system, with higher expression in the MOE and lower expression in the VNO (Fig. 3B,D , and data not shown). Fezf2 mRNA was first detected in the olfactory pit at E10.5 and was localized to the ventromedial region from which the future VNO is derived (Fig. 3C) . After the VNO separated from the olfactory pit, Fezf2 mRNA was detected exclusively in the VNO and this expression pattern was maintained until postnatal stages (Fig. 3E , and data not shown).
The in situ hybridization data demonstrated that Fezf1 and Fezf2 preferentially demarcate two distinct parts of the olfactory system: MOE and VNO. To confirm the in situ hybridization results and further investigate the expression of Fezf1 and Fezf2 at the cellular level, we used two different reporter mouse lines. A Fezf1 þ/À strain generated in our laboratory that contains both Figure 3 . Expression of Fezf1 and Fezf2 transcripts during olfactory system development. Radioactive in situ hybridization was used to detect Fezf1 (A,B,D) or Fezf2 (C,E) expression. At E9.5 Fezf1 was detected in the olfactory placode (arrowheads in A). At E10.5 it is detected throughout the newly formed olfactory pits (arrowheads in B). Fezf1 remains strongly expressed in the MOE (arrowheads in D) and weakly in the VNO (arrows in D) at E14.5 and later stages (D, and data not shown). Alternatively, Fezf2 is specifically expressed in the VNO throughout olfactory system development (arrows in C,E). A, sagittal section; B-E, coronal sections. Scale bars ¼ 25 lm in A; 100 lm in E (applies to B-E).
Fezf1 and Fezf2 and olfactory development
The Journal of Comparative Neurology | Research in Systems Neuroscience EGFP and PLAP coding sequences under the control of the endogenous Fezf1 promoter ( Fig. 2A ) was used to investigate Fezf1 expression. In the Fezf2 mutant allele generated previously (Chen et al., 2005a (Chen et al., , 2008 , even though an EGFP-ires-PLAP cassette was used to replace the genomic region encoding the Fezf2 open reading frame, EGFP protein was not detected in the mice carrying the mutant allele. Thus, to examine Fezf2 expression at a cellular level, instead of using the PLAP marker in the Fezf2 mutant allele we utilized a Fezf2-EGFP transgenic mouse line carrying an EGFP marker under the control of the Fezf2 promoter, which was produced by the GENSAT project using a modified bacterial artificial chromosome (Gong et al., 2003) . Consistent with the in situ hybridization results, at E10.5 and E12.5 Fezf1-EGFP was strongly expressed in cells across the full extent of the olfactory epithelium including the region that gives rise to the VNO (Fig. 4A,B,A 0 for MOE, G,H,G 0 for VNO). As development proceeded, Fezf1-EGFP expression remained high in the MOE (Fig. 4C-F) and decreased in the VNO (Fig. 4I-L) . After E14.5, Fezf1-EGFP expression within the MOE became restricted to OSNs and the basal progenitor cell layer in the MOE and was excluded from the supporting cell layer (Fig. 4D-F Fig. 4J-L) , and was detected in very few neurons in the VNO at P0 (Fig. 4L ,L 0 ).
In contrast to Fezf1-EGFP, expression of Fezf2-EGFP was restricted to the VNO. At E10.5, when VNO morphogenesis is first discernible as a local thickening of the neural epithelium in the ventromedial region of the olfactory pit, high Fezf2-EGFP expression was detected in the region that will become the VNO (Fig. 4S,S 0 ). To our knowledge this identifies Fezf2 as the earliest marker distinguishing the region of the olfactory pit that gives rise to the VNO from the rest of the olfactory pit. Fezf2-EGFP expression persisted in the VNO during its separation from the MOE (Fig. 4T,U) . Prior to E14.5 Fezf2-EGFP was expressed at high levels in most cells of the developing VNO (Fig. 4S ,T,S 0 ). However, after E14.5 Fezf2-EGFP expression became restricted to the apical sustentacular cell layer of the VNO (Fig. 4V-X,X 0 ). This dynamic transition was complete by E18.5 and persisted until postnatal stages (Fig. 4X ,X 0 , and data not shown). No Fezf2-EGFP expression was detected in cells of the MOE at any age ( Fig. 4M -R,M 0 ,R 0 ). Taken together, the in situ hybridization data and cell labeling with Fezf1-EGFP and Fezf2-EGFP markers demonstrate that expression of Fezf1 and Fezf2 is largely mutually exclusive; Fezf1 is preferentially expressed in the MOE and Fezf2 is exclusively expressed in the VNO during their development. Moreover, after E14.5 Fezf1 and Fezf2 become restricted to progenitors and neurons of the MOE and sustentacular cells of the VNO, respectively.
The mechanisms regulating segregation of the MOE and VNO from a common olfactory primordium remains unknown. Because Fezf2 plays an essential role in specifying neuronal identity in the developing cerebral cortex, preferential expression of Fezf1 in the MOE and exclusive expression of Fezf2 in the VNO suggested that these two genes are involved in specifying MOE and VNO cell identities. We tested this possibility by analyzing development of the olfactory system in Fezf1 À/À , Fezf2 À/À , and À/À mice have been described previously (Hirata et al., 2006b; Watanabe et al., 2009) . Consistent with published data, when we examined the olfactory axon projections in Fezf1 À/À mice using the PLAP marker which was knocked into the Fezf1 mutant allele, we found that OSNs were present in Fezf1 À/À mice but their axonal projections failed to reach the olfactory bulb and instead formed a fasciculated bundle (compare Fig. 5A,B) . This defect was not observed in Fezf2 À/À animals ( Fig. 5C ), and Fezf1 À/À ; Fezf2 À/À mice showed no exacerbation of the OSN axonal defects in the Fezf1 À/À animals ( Fig. 5B,D) .
To characterize further the defects in MOE development in Fezf1
À/À mice, we performed immunohistochemistry to investigate expression of two markers for mature OSNs: olfactory marker protein (OMP) and MOE expressed G-protein alpha subunit Ga s/olf . Consistent with a previous report (Watanabe et al., 2009 ), OMP expression was dramatically decreased in OSNs of Fezf1 À/À mice at P0 (Fig. 6A ,B) and this same phenotype was observed in Fezf1 À/À ; Fezf2 À/À mice (Fig. 6D) . Similar to the defects in OMP expression, we also observed a significant decrease in the expression of Ga s/olf in OSN dendrites from both Fezf1 À/À and Fezf1 À/À ; Fezf2 À/À animals ( Fig. 6E,F,H) . Immunostaining for neural cell adhesion molecule (NCAM) and L1 cell adhesion molecule (L1) did not show any gross defects in MOE organization ( Fig.  6A-H ), suggesting that a pan-neuronal identity was developed in the MOE of Fezf1 mutant mice. Further, the defects in OMP and Ga s/olf expression were not observed in the MOE of Fezf2 À/À mice (Fig. 6C,G) , suggesting that Fezf1,
and not Fezf2, is required for MOE-specific maturation. We next performed in situ hybridization to examine expression of MOE signal transduction components. These included the cyclic nucleotide gated ion channel CNGA2 (Fig. 6I,J) , a subset of odorant receptors (ORs) (Fig. 6K,L) and a subset of trace amine-associated receptors (TAARs) (Fig. 6M,N) . Consistent with our observations for OMP and Ga s/olf , levels of these transcripts were decreased in the Fezf1 À/À MOE compared with controls ( Fig. 6I-N 
. Nuclei were visualized using SYTOX orange. At E10.5 and E12.5, Fezf1-EGFP is expressed throughout the future MOE and VNO (A,B,G,H,A 0 ,G 0 ). After E14.5 Fezf1-EGFP expression starts to decrease in the VNO and becomes restricted to progenitor and neuronal cell layers of the
. This transition is complete by E18.5 and persists postnatally (E,F,K,L,F 0 ,L 0 ). In contrast to the Fezf1-EGFP expression pattern, Fezf2-EGFP expression is restricted to the VNO throughout olfactory system development (M-X,M 0 ,S 0 ,R 0 ,X 0 ). At E10.5, when the VNO is first starting to differentiate from the olfactory pit, Fezf2-EGFP is strongly expressed throughout cells in the ventromedial anlage that will give rise to the VNO (S,S 0 ). Beginning at E14.5, Fezf2-EGFP expression undergoes a dynamic transition and becomes restricted to the sustentacular cell layer of the VNO (O-R;U-X,R 0 ,X 0 ). This expression pattern of Fezf2-EGFP is maintained postnatally (R,X,R 0 ,X 0 ). For all images, EGFP expression is shown in green and SYTOX orange staining is in purple.
, and X 0 represent the enlarged regions shown in the white boxes in A, F, G, L, M, R, S, and X. Scale bars ¼ 75 lm in X (applies to A-X); 30 lm in X 0 .
Fezf1 and Fezf2 and olfactory development (Fig. 7I,J) . Although Fezf1 was detected at low levels in the developing VNO (Fig. 4G -L,G 0 ,L 0 ), we did not observe a significant reduction of PLAP staining in the VNO of Fezf1 À/À mice compared to Fezf1 þ/À (Fig.   7A ,B,E,F). Furthermore, degeneration of the nascent VNO in Fezf2 À/À mice was not exacerbated by deletion of Fezf1 (compare Fig. 7D,H (Fig. 8A) . These genes encode VNO receptors, ion channels, components of VNO signal transduction, and VNO-specific transcription factors (Supporting Table S1 ). Thus, gene expression analysis demonstrates that in Fezf1 À/À mice the MOE fails to mature properly and instead adopts a VNO-like transcriptional identity. Unfortunately, due to the early degeneration of the VNO in Fezf2 À/À mice we were not able to perform a similar analysis for Fezf2-expressing VNO cells. (Trpc2) is expressed by all vomeronasal sensory neurons (VSNs) and is required for their function (Stowers et al., 2002) . In Fezf1 þ/À mice, Trpc2 is strongly expressed in the VNO and weakly in the MOE (Fig. 8B) . Strikingly, we observed significant upregulation of Trpc2 in the MOE of Fezf1 À/À animals (Fig. 8C ). Vomeronasal receptor class 1 and 2 genes (V1Rs and V2Rs, respectively) are important for pheromone detection and their expression is strongly enriched in the VNO. When we compared the expression of V1Rs and V2Rs in Fezf1 þ/À (Fig. 8D,F and Fezf2 À/À mice at E13.5. At this age we found no evidence demonstrating that loss of Fezf2 affects expression of Fezf1 (Fig. 9A,B) . This observation is consistent with the fact Fezf2 is not expressed in the MOE during development. Unfortunately, the early degeneration of the VNO in Fezf1 expression, we did not observe any significant change in the expression levels of Fezf2 in the MOE or VNO after loss of Fezf1 (Fig. 9C-F) . Consistent with these results, our microarray analysis did not show any increase in Fezf2 expression in purified Fezf1 À/À MOE cells at E18.5 (Supporting Table S1 ). Fezf1 and Fezf2 can function interchangeably in cell fate specification during development of the cerebral cortex
The lack of genetic and molecular evidence for crossinhibition between Fezf1 and Fezf2 prompted us to explore other possible mechanisms underlying their functions. The sequences of FEZF1 and FEZF2 proteins show a high degree of similarity. They both contain a putative C-terminal DNA binding domain consisting of six C 2 H 2 zinc-finger motifs and an N-terminal region with homology to the engrailed repressor domain, which can interact with the groucho/TLE family of corepressors ( Fig. 10A ) (Shimizu and Hibi, 2009) . In fact, the zinc-finger motifs of these two proteins are 97% identical (Fig. 10A ). This high degree of similarity in their DNA binding domains suggests that FEZF1 and FEZF2 have the capacity to bind the same DNA regulatory sequences and likely regulate similar sets of genes.
The expression patterns of Fezf1 and Fezf2 during olfactory system development and the phenotype of Fezf1 À/À mice are consistent with the hypothesis that they regulate common gene targets. (Fig. 10M) . To test this, we performed a misexpression assay to ascertain whether Fezf1 and Fezf2 can function interchangeably in cell fate specification. Instead of using the olfactory system, we performed this assay in the developing cerebral cortex, since this brain region is much more amenable for surgical manipulation to test gene function in vivo. During development of the cerebral cortex, Fezf1 is not expressed in cortical neurons (Hirata et al., 2006a; Shimizu et al., 2010) . However, Fezf2 is expressed in subcortical projection neurons of the cerebral cortex and is both necessary and sufficient for the development of subcortical axons (Chen et al., 2005a (Chen et al., ,b, 2008 Molyneaux et al., 2005) . Previously, we have demonstrated that misexpression of Fezf2 in corticocortical projection neurons An alignment of the zinc-finger motifs shows only three amino acid differences (*), corresponding to 97% identity between the two proteins. B-L: Misexpression of Fezf1 in corticocortical projection neurons of the cerebral cortex is sufficient to redirect their axons subcortically, similar to previously reported results for Fezf2 misexpression (Chen et al., 2008) . When Fezf1 and EGFP were electroporated into layer 2/3 neurons in utero (H-L) their axons are redirected to the striatum (J), thalamus (K), and pons (L). No GFP þ axons were detected in these brain regions when only EGFP was misexpressed (B-F). Our model predicts that Fezf1 promotes MOE development and Fezf2 promotes VNO development by preventing progenitors and sensory neurons of the MOE and progenitors and supporting cells of the VNO from assuming a VNO sensory neuron identity (M). The diagram in A is not drawn to scale. Scale bars ¼ 1 mm in H (applies to B); 75 lm in L (applies to C-L).
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The Journal of Comparative Neurology | Research in Systems Neuroscience prevents these neurons from sending axons to other cortical areas (their normal axon targets), and instead redirects their axons to subcortical targets such as the thalamus and spinal cord (Chen et al., 2008) . To test whether FEZF1 and FEZF2 can regulate similar sets of genes, we ectopically expressed Fezf1 in corticocortical projection neurons and assayed the effects on their axonal projections. Plasmids encoding the FEZF1 protein under control of the cytomegalovirus (CMV) early gene promoter and chicken b-actin enhancer were introduced into corticocortical projection neurons at E15.5 using in utero electroporation. Additionally, plasmids encoding the EGFP protein under the same promoter and enhancer were coelectroporated to label cell bodies and axons of the electroporated neurons. Following surgery the embryos were returned to the abdomens of pregnant female mice and allowed to develop to full term. Brains from the electroporated embryos were collected at P5. In brains electroporated with EGFP plasmids alone, GFP labeled axons are present in the striatum (Fig. 10D) but not in the thalamus (Fig. 10E ) or the pons (Fig. 10F) , which are the axonal targets of subcortical neurons. Strikingly, in brains electroporated with FEZF1 and EGFP-expressing plasmids, many GFP labeled axons are present in the striatum (Fig. 10J) , thalamus (Fig. 10K) , and pons ( Fig. 10L) , similar to the effect of misexpressing FEZF2 in corticocortical projection neurons (Chen et al., 2008) . This result demonstrates that FEZF1 and FEZF2 can regulate expression of common genes in vivo.
DISCUSSION
The mechanisms specifying the MOE and VNO, two functionally and anatomically distinct organs, from a common olfactory pit have not been well defined. In this study we focused on the functions of two zinc-finger transcription factors, Fezf1 and Fezf2, in murine olfactory development. We found that Fezf2 is required for survival and proliferation of VNO progenitors and that Fezf1 regulates the maturation and identity of MOE sensory neurons.
During development, Fezf1 and Fezf2 are expressed in the olfactory pit at an early stage and demarcate distinct regions of the olfactory primordium. While Fezf1-expressing cells are distributed along the full length of the olfactory pit, Fezf2 expression is restricted to the ventromedial region that gives rise to the VNO, making Fezf2 the earliest marker for future VNO cells. Immediately after the VNO segregates from the MOE at E13.5, Fezf1 is expressed in both the MOE and VNO. After E14.5, while Fezf1 expression in OSNs and progenitors of the MOE steadily increases, its expression in the VNO decreases, and very few VNO sensory neurons still express Fezf1 at birth. Conversely, Fezf2 expression in the VNO is dynamic; prior to E14.5, Fezf2 is expressed throughout the VNO neuroepithelium. After E14.5, when supporting cells and VSNs segregate into distinct layers, Fezf2 expression becomes restricted to the sustentacular cell layer and is excluded from differentiating VSNs. These specific and dynamic expression patterns of Fezf1 and Fezf2 suggest that they regulate cell identity during olfactory system development.
Indeed, in the developing cerebral cortex Fezf2 plays an essential role in establishing projection neuron identity. In the cerebral cortex, Fezf2 is initially expressed in progenitor cells. When neurogenesis begins, Fezf2 expression is restricted to subcortical projection neurons and regulates their identities (Chen et al., 2005a (Chen et al., ,b, 2008 Molyneaux et al., 2005; Hirata et al., 2006a; Shimizu et al., 2010) . In Fezf2 À/À mice, the subcerebral neurons fail to develop and instead adopt the identities of alternative projection neuron subtypes; they express molecular markers of callosal and corticothalamic neurons and project axons to the normal targets of callosal and corticothalamic neurons (Chen et al., 2005a (Chen et al., ,b, 2008 Molyneaux et al., 2005) . Current literature supports the idea that Fezf2 promotes subcerebral neuron identity by repressing alternative callosal and corticothalamic fates (Chen et al., 2008) . The dynamic expression pattern of Fezf2 in the olfactory system is very similar to that observed in the cerebral cortex. It is expressed in VNO precursor cells before E14.5. However, when supporting cells are generated, Fezf2 expression becomes restricted to the sustentacular cells and excluded from VNO neurons. Based on a similarly dynamic expression pattern for Fezf2 in the cerebral cortex and VNO, and the mechanisms of Fezf2 regulation of projection neuron identities in the cerebral cortex, we propose that Fezf2 promotes supporting cell identity by repressing expression of VSN-enriched genes. Unfortunately, the early and rapid degeneration of the VNO in Fezf2 À/À mice prevented us from directly investigating whether Fezf2 represses VNO sensory neuron identity in supporting cells. Fezf1 is essential for the axons of OSNs to project into the olfactory bulb (Hirata et al., 2006b; Watanabe et al., 2009 ). In our study we found that, in addition to regulating axonal development, Fezf1 regulates the development of OSNs in the MOE through repression of VSN-enriched genes. In Fezf1 À/À mice the expression of many MOEenriched genes is reduced and we observed ectopic expression of many VNO-enriched genes. These results demonstrate that by repressing VSN-enriched gene expression, Fezf1 ensures that OSNs fully differentiate and mature. Since olfactory axons do not reach the olfactory bulb in Fezf1 À/À mice, possibly due to a failure to penetrate the basal lamina layer of the brain (Watanabe et al., 2009) , we are unable to determine whether the target choice of Fezf1 mutant OSNs is switched from the main olfactory bulb to the accessory olfactory bulb. There are two identifiable protein domains in the FEZ proteins: an engrailed homology domain and the zinc-finger motifs. Both protein domains are almost identical between FEZF1 and FEZF2, suggesting that they can regulate common gene targets. Indeed, we observed the same effects on axonal targeting when either FEZF1 or FEZF2 was misexpressed in corticocortical projection neurons in the cerebral cortex. Recently, Shimizu et al. (2010) reported that FEZF1 and FEZF2 both directly repress transcription of Hes5. This report and our results are consistent with the hypothesis that Fezf1 and Fezf2 regulate cell fate during development of the olfactory system through repression of VSN-enriched genes in either progenitors and sensory neurons of the MOE or supporting cells of the VNO.
Our study helps to illuminate the molecular mechanisms that regulate the contrasting identities of the MOE and VNO, two functionally and anatomically distinct organs that arise from a common placode during development. Separate olfactory subsystems first appeared in the aquatic ancestors of modern tetrapods, and this subsystem organization has been maintained in primates (Swaney and Keverne, 2009 ). We propose that Fezf1 and Fezf2 function to prevent OSNs in the MOE and supporting cells in the VNO from assuming a VNO sensory neuron identity. FEZF1 and FEZF2 likely accomplish this task either through activation or repression of target genes. The mixed cell identities observed in the MOE of Fezf1 À/À mice suggests that, although Fezf1 plays an important role in repressing VSN identity, there are likely other key regulators that act either upstream or in parallel to promote OSN fate specification.
